Fraunhofer Institute for Toxicology and Experimental Medicine

Fraunhofer ITEM: News


News / 3.11.2022

Development of RNA-based drugs

Project iGUARD receives 1.5 million euros follow-up funding for rapid therapies against viral diseases.

BIOSYNTH project: DNA for data storage

Modular high-throughput microplatform for future mass data storage based on synthetic biology

Press release / 4.10.2022

Medical engineering to help assess nanoparticles

Fraunhofer scientists are developing the exposure device NanoCube whose integrated multi-organ chip detects interaction of nanoparticles and lung cells. 


News / 29.9.2022

Publication in Nature Communications

Airway basal cells as key cells in the pathogenesis of pulmonary fibrosis

News / 25.8.2022

Understanding Cabin Air Quality

The recently launched research project ”Cabin air quality III“ is aimed at assessing long-term effects of contaminants that aircraft passengers and crew members are exposed to on board.


News / 29.8.2022

Designer cells: novel immune cell platforms for health research

Start of Fraunhofer Attract group headed by Prof. Dr. Nico Lachmann.

Press release / 29.6.2022

Project FibroPaths®

Therapeutic modulation of organ fibrosis in biochip format. 

Press release / 28.10.2022

High Performance Center at the COMPAMED 2022

Plasma treatment during 3D printing improves acceptance of implants.

Our research and development expertise

For more than four decades, we have been developing solutions for human health


Cardiopulmonary research

Through the establishment of a Division of Cardiovascular Research in 2021, the long-standing expertise in lung research is experiencing a synergetic further development of high clinical relevance. 

Medical and Pharmaceutical Engineering

Next to innovative inhalation technologies, our focus is on developing novel technologies for administration of therapeutic aerosols by means of smart drug/device combination products.


Malignant disease research

The Fraunhofer ITEM Division of Personalized Tumor Therapy in Regensburg is aimed at understanding a patient’s individual condition, establishing appropriate diagnostics and optimizing therapies.

Bioinformatics and AI

Our researchers develop methods for preparation, analysis and visualization of biomedical data, as well as data models and data analysis pipelines. The focus is on the mapping of cellular and regulatory processes and their translation into applications.



Based on the next generation risk assessment concept, Fraunhofer ITEM develops new assessment strategies to provide predictive models for assessing the safety of compounds, active pharmaceutical ingredients and drugs.


Immunology and infection research

The development, formulation and mode of delivery of anti-infective agents, for example for inhaled administration as drug aerosols, are research topics of current interest at the institute.

Our services


Chemical Safety and Assessment


Translational Biomedical Engineering


Personalized Tumor Therapy


Fraunhofer ITEM

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Nikolai-Fuchs-Strasse 1
30625 Hannover

Phone +49 511 5350-0



Biotech Innovation Spotlight: Liquid Biopsy

The conference “Biotech Innovation Spotlight: Liquid Biopsy” will be held as a digital event on November 22, 2022. Dr. Bernhard Polzer from Fraunhofer ITEM will contribute an oral presentation.
Read more


ESTIV 2022

This year’s international congress of the European Society of Toxicology In Vitro will be held in Sitges (Barcelona), Spain, from November 21 to 25, 2022. Scientists from Fraunhofer ITEM will contribute an oral presentation and several poster presentations.
Read more



This year’s MEDICA/COMPAMED will be held in Düsseldorf, Germany, from November 14 to 17, 2022. As part of the High-Performance Center Medical and Pharmaceutical Engineering, Fraunhofer ITEM will be present as an exhibitor at the joint Fraunhofer booth.
Read more


MRS 19th Biennial Congess

The 19th Biennial Congress of the Metastasis Research Society will be held in Bueros Aires, Argentina from November 13 to 16, 2022. Fraunhofer ITEM will contribute an oral presentation.
Read more

About Fraunhofer ITEM

The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of 76 institutes and research institutions of the Fraunhofer-Gesellschaft, the world’s leading applied research organization. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on cardiopulmonary research, our R&D portfolio includes three business areas: Drug Development, Chemical Safety and Translational Biomedical Engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.

With a staff of around 450 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.


More information about Fraunhofer ITEM